RecruitingNCT04582916
PET scans of cyclooxygenase in depression
About this title
Read the official source — NCT04582916Medication studyAges 18–70United States
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
What will I do during this study?
Participants in this imaging study receive intravenous radiotracers followed by PET brain scans. The same tests are used across the study groups; the record does not detail the number of visits.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 20, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 64
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04582916
- Official title
Show the full official title
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Does this study involve medication?
Yes. The study involves medication, including 11C-MCI and 11CPS13.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
